ABL Share Price

Open 46.35 Change Price %
High 46.88 1 Day -0.01 -0.02
Low 46.35 1 Week 0.00 0.00
Close 46.72 1 Month 0.63 1.37
Volume 719 1 Year 9.52 25.59
52 Week High 48.18
52 Week Low 35.00
ABL Important Levels
Resistance 2 47.21
Resistance 1 47.01
Pivot 46.65
Support 1 46.43
Support 2 46.23
ETR Germany Most Active Stocks
DTE 15.31 -2.11%
DTE 15.31 -2.11%
DTE 15.31 -2.11%
DTE 15.31 -2.11%
DTE 15.31 -2.11%
DBK 14.13 1.29%
DBK 14.13 1.29%
EOAN 10.38 2.47%
EOAN 10.38 2.47%
CBK 11.88 0.93%
ETR Germany Top Gainers Stocks
S9H 0.16 45.45%
M3B 0.84 21.74%
CR8 7.33 20.16%
R3Q 0.12 20.00%
5M71 39.00 13.70%
WI4 1.12 13.13%
KU2 210.50 11.97%
SONA 35.85 11.75%
SONA 35.85 11.75%
ELG 27.09 11.53%
ETR Germany Top Losers Stocks
MPI 0.25 -98.98%
MPI 0.25 -98.98%
APL 2.60 -34.18%
APL 2.60 -34.18%
APL 2.60 -34.18%
U9R 10.60 -24.56%
BIO 24.70 -11.41%
BIO 24.70 -11.41%
BIO 24.70 -11.41%
BIO 24.70 -11.41%

Abbott Laboratories (ETR: ABL)

ABL Technical Analysis 4
As on 1st Nov 2017 ABL Share Price closed @ 46.72 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 40.88 & Buy for SHORT-TERM with Stoploss of 44.28 we also expect STOCK to react on Following IMPORTANT LEVELS.
ABL Target for May
1st Target up-side 48.42
2nd Target up-side 49.61
3rd Target up-side 50.8
1st Target down-side 45.04
2nd Target down-side 43.85
3rd Target down-side 42.66
ABL Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.abbott.com
ABL Address
100 Abbott Park Road
Abbott Park, IL 60064
United States
Phone: 847-937-6100
ABL Latest News
Interactive Technical Analysis Chart Abbott Laboratories ( ABL ETR Germany )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Abbott Laboratories
ABL Business Profile
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome, intrahepatic cholestasis or depressive symptoms, gynecological disorders, dyslipidemia, hypertension, hypothyroidism, pain, fever, and inflammation; and regulates physiological rhythm of the colon, as well as provides hormone replacement therapy and anti-infective and influenza vaccines. The company’s Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company’s Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular diseases. Abbott Laboratories also offers blood glucose and glucose monitoring systems, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.